Lisa Catalli, ACTHIV 2021: Hepatitis C and HIV Co-infection

It was a pleasure to speak with Lisa Catalli (Department of GI/Hepatology, UCSF Medical Center, University of California, San Francisco, CA, USA) to discuss practical advice and diagnostic tools for hepatitis C and HIV treatment.

The abstract entitled: ‘Pre-Treatment Evaluation of Hepatitis C in HIV and On-Treatment Management Cases’ was presented at the ACTHIV Virtual Conference 2021, May 20-22, 2021.

Questions:

1.  What information is needed when conducting an HCV-focussed evaluation and work up for direct acting antiviral therapy? (0:10)
2.  What tools can predict cirrhosis and what are the next steps if cirrhosis is predicted? (1:13)
3. What tools are available to guide HCV treatment? (3:00)
4. What other advice would you give to practitioners when facing the challenges of HCV-HIV coinfection? (3:50)

Disclosures: Lisa Catalli has nothing to disclose in relation to this video.

Support: Interview and filming supported by Touch Medical Media.

Filmed in coverage of the ACTHIV Virtual Conference 2021.